Collectively, these data suggest that ATOH1 acts as an oncogene in medulloblastomas; however, ATOH1-mediated tumor suppressor activity has been demonstrated in other signaling pathways and highlights the importance of context when considering these pathway interactions (Bossuyt et al., 2009a,b). Here, ATOH1 is linked to medulloblastoma.